Objective
The current analysis examines whether opioid use is associated with
insomnia in a community sample, as the consequences of the growing epidemic
of prescription opioid use continue to cause public health concern.
Study Design
A cross-sectional study including 8,433 members in a community
outreach program, HealthStreet, in Northeast Florida.
Methods
Community Health Workers (CHWs) assessed health information,
including use of opioids (i.e., Vicodin®, Oxycodone, Codeine,
Demerol®, Morphine, Percocet®, Darvon®, Hydrocodone)
from community members during field outreach. Insomnia was determined based
on self-report: "Have you ever been told you had, or have you ever
had a problem with insomnia?" Summary descriptive statistics were
calculated and logistic regression modelling was used to calculate adjusted
odds ratios (ORs) with 95% confidence intervals for insomnia, by
opioid use status, after adjustment for demographics and other
covariates.
Results
Among 8,433 community members recruited (41% male;
61% black), 2,115 (25%) reported insomnia, and 4,200
(50.3%) reported use of opioids. After adjusting for covariates,
opioid users were significantly more likely to report insomnia than
non-users (adjusted OR, 1.42; 95% CI, 1.25 –1.61).
Conclusion
Insomnia was 42% more likely among those who reported using
prescription opioids compared to those who did not. With one half of the
sample reporting prescription opioid use, and a fourth reporting insomnia it
is important to further investigate the relationship between the two.
Findings provide useful preliminary information from which to conduct
further analyses.